Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Tomography, X-Ray Computed × Clear all

Sponsor

Conditions

Prostatic Neoplasms 5 Lymphoma 3 Squamous Cell Carcinoma of Head and Neck 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Hepatocellular 2 Burkitt Lymphoma 2 Vasculitis 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Osteomyelitis 1 Nose Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Pulmonary Nodules 1 Metastatic Solid Tumors 1 Lymphoproliferative Disorders 1 Lymphomatoid Granulomatosis 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Heart Diseases 1

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡